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Background: A double-blinded, placebo-controlled, cross-over design was used to investigate whether two
different sodium citrate dihydrate (Na-CIT) supplementation protocols improve 200 m swimming performance in
adolescent swimmers.
Methods: Ten, male swimmers (14.9 ± 0.4 years of age; 63.5 ± 4 kg) performed four 200 m time trials with the
following treatments: acute (ACU) supplementation (0.5 g kg−1 administered 120 min pre-trial), acute placebo
(PLC-A), chronic (CHR) supplementation (0.1 g:kg−1 for three days and 0.3 g kg−1 on the forth day 120 min pre-trial),
and chronic placebo (PLC-C). The order of the trials was randomized, with at least a six-day wash-out period
between trials. Blood samples were collected by finger prick pre-ingestion, 100 min post-ingestion, and 3 min
post-trial. Performance time, rate of perceived exertion, pH, base excess, bicarbonate and lactate concentration were
measured.
Results: Post-ingestion bicarbonate and base excess were higher (P < 0.05) in both the ACU and CHR trials
compared to placebo showing adequate pre-exercise alkalosis. However, performance time, rate of perceived
exertion as well as post-trial pH and lactate concentration were not significantly different between trials. Further
analysis revealed that five swimmers, identified as responders, improved their performance time by 1.03% (P < 0.05)
and attained higher post-trial lactate concentrations in the ACU versus PLC-A trial (P < 0.05). They also had
significantly higher post-trial lactate concentrations compared to the non-responders in the ACU and CHR trials.
Conclusions: Acute supplementation of Na-CIT prior to 200 m swimming performance led to a modest time
improvement and higher blood lactate concentrations in only half of the swimmers while the chronic Na-CIT
supplementation did not provide any ergogenic effect in this group of adolescent swimmers.
Trial registration: Clinicaltrials.gov NCT01835912.
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Alkalizing agents have been used in high performance
sports as a strategy to postpone the onset of fatigue during
high intensity exercise by slowing the decline in muscle
and blood pH [1,2]. Studies have confirmed that in-
creasing the extracellular pH, via an alkalizer, promotes
the efflux of lactate and H+ from the active muscles* Correspondence: nklentrou@brocku.ca
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unless otherwise stated.[1,3-5]. Therefore, artificially inducing alkalosis prior to
anaerobic exercise may reduce intracellular acidosis and
increase the time to fatigue [6,7]
The process known as “bicarbonate loading”, in which
sodium bicarbonate is ingested pre-performance, is a
popular method of blood alkalization among athletes
[6,8]. According to a recent meta-analysis by Carr et al.
[8], sodium bicarbonate enhances performance by 1.7%
(±2.0%) for a 60 sec maximal effort, with a dose of
0.3 g kg−1 of body mass being the optimal dose. How-
ever, the gastrointestinal (GI) acceptance profile ofLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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adequately tolerate the doses needed to elicit an ergogenic
effect [6,9]. Thus, ingesting sodium bicarbonate in high
enough doses to induce an adequate modification of the
acid–base balance during exercise can be detrimental to
performance [6,9,10]. Sodium citrate (Na-CIT) is another
alkalizing agent that has been studied in sports over a
broad array of doses, times and distances but the results
on its ergogenic effect have been inconclusive [2-4,10-14].
Indeed, the meta-analysis by Carr et al. [8] reported an
unclear effect on performance (0.0 ± 1.3%) for a 60 sec
maximal effort, with a dose of 0.5 g kg−1. Due to this
uncertainty, in combination with its lower commercial
availability, Na-CIT has not been used as an alternative
to sodium bicarbonate although it has a higher GI toler-
ance [2,5,6]. Na-CIT can enter the sarcolemma through
a recently discovered plasma membrane citrate trans-
porter [15], providing new evidence to support its po-
tential effect on performance.
Competitive swimming is an ideal model for studying
the effectiveness of alkalizing agents due to its high reli-
ance on anaerobic metabolism. Events range in duration
from 22 sec (50 m freestyle) to 15 min (1500 m freestyle)
with the highest blood lactate concentrations found in
the 200 m (~2 min) events. Typical post-race blood
lactate concentrations for these events are 6.4, 9.1, and
14.0 mmol/L in the 1500 m, 50 m, and 200 m events,
respectively [16]. Furthermore, swimmers often com-
pete in several events within a 30–90 min time frame
during any given session. Swimmers must also contend
with restrictions placed on their breathing frequency
during intense exercise as a result a unique interaction
between muscle physiology, technique, and ventilation.
Exercise hyperpnoea is limited during high intensity
swimming because turning or lifting the head to breathe
may jeopardize execution of proper stroke technique
[17,18]. Indeed, swimming requires that the athlete sustain
a high rate of energy expenditure and the suspension of
breathing for approximately 20 - 30% of a race [19]. Given
these limitations and the physiological consequences, it
is likely that anaerobic metabolism is a significant con-
tributor to metabolic power in competitive swimming,
and may also be a primary determinant of fatigue and
limitations in performance [7].
Another reason why competitive swimming is an appro-
priate model for studying the effectiveness of alkalizing
agents is that swimmers are often young when they reach
elite level competition; among the swimming medalists in
the 2012 Olympics (n = 78), twenty-five were under 21
and eight were under 18 years old. This creates a highly
competitive environment, where 80% of elite adolescent
athletes are using supplements and other non-doping
strategies to improve performance [20]. It is, therefore,
surprising that there is such a lack of research on theeffectiveness of such ergogenic aids in this population
[20], especially when acid base regulation in adolescents
may be significantly different than that of adults.
The overall purpose of this study was to evaluate the
ergogenic effect of two Na-CIT supplementation proto-
cols, previously used in adults, in adolescent swimmers.
Specifically, the types of Na-CIT supplementation pro-
tocols that have been previously applied include an
acute (single) dose and a chronic (multi-day) dose prior
to performance. During the acute delivery mode partici-
pants take one single dose (0.3 - 0.6 g∙ kg−1 body mass
Na-CIT) 60 to 180 min before the start of competition
[2-4,11,13] while a chronic dose (0.3 g∙ kg−1 body mass
Na-CIT) is given for a number of days prior to perform-
ance [21]. Chronic dosing of alkalizing agents was first
employed by McNaughton et al. [22] using sodium bicar-
bonate in an effort to elicit an ergogenic effect while min-
imizing GI upset, which often occurs with acute dosing
protocols. Based on these studies, a double-blinded, pla-
cebo controlled, cross-over design was used to investigate
the effects of an acute versus a chronic Na-CIT supple-
mentation protocol on 200 m swimming performance and
acid–base parameters in male, adolescent swimmers.Methods
Participants
Sample size was calculated using pre- and post-trial
blood lactate concentrations from a published 5 km run
trial in adults, an 80% power, and a 0.05 level of signifi-
cance; this resulted in a minimum sample size of 8 [13].
Thus, ten, well trained, male, adolescent swimmers (14.9 ±
0.4 years of age; 63.5 ± 4.0 kg), were recruited from com-
petitive swimming clubs in Ontario, Canada to participate
in the current study. All participants had at least 3 years
experience in competitive swimming and had achieved
regional, provincial and/or national level qualifications.
Informed consent was obtained from all participants
and their parents. The study procedures were approved
by the Health Canada Natural Health Products Direct-
orate and the Brock University Research Ethics Board.Experimental design
The current study used a randomized, double-blinded,
placebo controlled, cross-over design. All participants per-
formed four swimming trials under four treatment condi-
tions determined by the amount of, and time over which,
Na-CIT dihydrate [(HCOONa)2 * 2(H2O)] was ingested.
Specifically, all participants randomly performed the
following 4 trials; two experimental: 1) acute (ACU), 2)
chronic (CHR), and 2 placebo: 3) acute placebo (PLC-
A), and 4) chronic placebo (PLC-C). Each Na-CIT sup-
plementation trial was separated by at least a six-day
washout period. The order of trials was randomly
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number generator.
The study was conducted during the mid-season train-
ing period (March-April) in a 4-week window without
competition in order to minimize fluctuations in training
volume and tapering effects. During this period, the swim-
mers trained 14–19 hours/week including 12–16 hours of
swimming sets and 0–5 hours of weight training. Their
training consisted of: a) seven to nine variant-load swim-
ming sessions per week of medium to high-intensity, and
b) two to three constant-load weight training sessions per
week. The participants were instructed to maintain their
individual training programs. Additionally, they were
advised to refrain from any high-intensity exercise and
to continue their nutritional habits between the four
swimming trials.
Supplementation protocol
Sodium Citrate (Victoria Compounding Pharmacy) was
delivered in solution with 500 mL of flavored water
(Crystal Light Pink Lemonade); the placebo consisted of
similarly flavored water (Crystal Light Pink Lemonade).
Ten adult volunteers tested multiple flavors (Strawberry-
Banana-Orange, Lemon-Lime, and Pink Lemonade),
with and without Na-CIT, to find an optimal masking
flavor in an effort to maintain blinded supplementation.
Volunteers were blinded to which samples contained
Na-CIT. After sampling and revealing which drinks con-
tained Na-CIT, the volunteers chose the Pink Lemonade
as the best masking flavor for the supplementation
protocols.
According to McNaughton [4], the optimal ACU dose
of Na-CIT was 0.5 g kg−1; therefore, the ACU trial in-
volved taking 0.5 g kg−1 of Na-CIT in solution with
500 mL of flavored water consumed 120 min prior to
performance according to the timing protocol described
by Oopik et al. [13]. The CHR dose involved taking
0.1 g kg−1 of Na-CIT three times per day for three days,
and on the fourth day, a final dose of 0.3 g kg−1 was
consumed 120 min prior to performance as previously
done in adult athletes [21]. The PLC-A and PLC-C in-
volved 500 mL of flavored water taken with the same
frequency and timing as their corresponding experi-
mental trial. The doses and the ingestion time frame of
120 min pre-trial were chosen to match previously pub-
lished protocols using Na-CIT supplementation [13,23].
It is recognized that there are different ingestion times
suggested in the literature, anywhere from 60 to 120 min
pre-performance [6,22]. However, since all previous stud-
ies are in adult athletes and this is the first exploratory
pediatric study the decision was to start with the time
frame previously used for Na-CIT [13,21].
The placebo and Na-CIT bottles were coded by an inde-
pendent researcher, and the key was used only at the timeof data analysis by the primary investigator. Swimmers
were simply asked anecdotally if they knew which solution
they were ingesting and if they were experiencing any GI
discomfort throughout each trial. In all cases, swimmers
did not know which solution they were ingesting and no
GI discomfort was reported during the study.
Swimming trials
The 200 m swimming trials were conducted in a short-
course (25 m) pool. Participants swam a 200 m event of
their preferred stroke at maximal effort. The choice of
stroke was given to increase participant motivation and
provide real life data. For each swimmer, the same stroke
was used for all four trials (backstroke n = 1, breaststroke
n = 2, freestyle n = 6, individual medley n = 1). The breast-
strokers and three freestylers (n = 5) were National age
group qualifiers, the backstroker and 2 freestylers were
provincial qualifiers (n = 3), and the rest were regional
qualifiers (n = 2). All swimmers wore the same, regular
competition apparel across the four trials. Warm-up and
warm-down procedures were based solely on each swim-
mer’s typical competition routine. Every trial was done
during the same time of the day (5:00–6:00 pm) in order
to minimize diurnal and daily variations. The 200 m swim
began with a dive from the blocks with a typical competi-
tion signal by the same starter. Performance times and
rates of perceived exertion (RPE) were recorded at the end
of each trial. Performance times were recorded with a
manual stopwatch by the same investigator.
Blood sampling and analysis
Blood was collected pre-ingestion, 100 min post-ingestion
(20 min pre-trial), and 3 min post-trial. The post-trial col-
lection time was chosen based on previous research sug-
gesting that blood lactate reaches its highest concentrations
between 3–5 min post-exercise [16,24-26]. A mixed blood
sample was collected by finger prick and analyzed immedi-
ately using an automated lactate analyzer (Arkray Lactate
Pro LT-1710) to determine blood lactate concentrations.
Using the same finger prick, ~95 μL blood was collected
into a plain capillary tube and immediately analyzed for
base excess (BE), bicarbonate, pH, and PCO2 using an
i-STAT 1 analyzer (Abbott Point of Care). The blood
collection was consistently done by the same researcher
for each analyzer and for all trials.
Statistical analysis
Sample size was calculated using pre- and post-trial blood
lactate concentrations from a published 5 km run trial in
adults, an 80% power, and a 0.05 level of significance; this
resulted in a sample size of 8 [13]. The Statistical Package
for Social Sciences (SPSS Inc., Version 19.0) was used for
all data analyses, and statistical significance was accepted
at P < 0.05. Descriptive data are presented as mean ± SEM.
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pare performance time and blood lactate concentrations
among trials, and RPE to establish equal effort among all
trials. Due to missing data points, BE, bicarbonate, pH,
and PCO2 were analyzed for differences between trials
using an ANOVA and the assumption of equal sample
sizes was not satisfied. This was accounted for in simple
comparisons using a Gabriel’s post-hoc. In addition, the
time effects within trials for all physiological variables
were analyzed using repeated measures ANOVA.
Further analysis was conducted within two sub-groups:
“responders” and “non-responders”, in which the athletes
were “barred” on the basis of performance differences.
Participants were classified as responders if they had a
performance improvement greater than 0.4% in the
ACU versus the PLC-A trial. This is considered a sig-
nificant competitive improvement estimated by analyz-
ing the magnitude of the improvement needed for a
swimmer ranked in the Top 10 in the World to medal
in the Olympics [27,28]. Of the ten swimmers, five were
identified as responders. Anthropometric data were
compared between responders and non-responders for
differences in age and body mass using an independent
sample T-test. Due to the small sample size, the responders’
group did not satisfy the assumptions of normality for time
and lactate concentrations, and therefore, were analyzed
with a non-parametric Wilcoxon Signed Ranks test. Lactate
concentrations of responders and non-responders were
compared using a Mann–Whitney U test.
Results
There were no differences in performance times between
the PLC-A and PLC-C trials (143.5 ± 4.7 and 143.5 ±
5.4 sec, respectively), indicating that the young swimmersFigure 1 Absolute change in performance time for the responders (n
acute placebo (PLC-A) supplementation trials. Performance was signific
a different swimmer.were able to accurately reproduce their performance.
When comparing the PLC-A versus the ACU trial, the
PLC-C versus the CHR trial, and the ACU versus the
CHR trial for all swimmers, no significant differences were
found. Furthermore, RPE was not statistically different
across all trials, confirming that the perception of effort
was unaffected by any perception (or absence of ) in
regards to the nature of the supplement.
The five swimmers, identified as responders, improved
their performance times by 1.03% (P < 0.05) in the ACU
compared to the PLC-A trial (Figure 1). This improve-
ment was statistically significant and more than the set
minimum improvement of 0.4%. However, even after
applying the 0.4% minimum improvement requirement
there were no significant performance differences in the
CHR compared to the PLC-C trial. In addition, no sig-
nificant ergogenic or ergolytic effect was found in the
non-responders. Although statistically non-significant,
the five swimmers classified as responders were older
and had a higher body mass and BMI than the non-
responders (Table 1).
As expected, blood lactate concentrations were sig-
nificantly increased from post-ingestion to post-trial
(P < 0.05), across all trials. The responders had signifi-
cantly higher blood lactate concentrations in the ACU
compared to the PLC-A trial (P < 0.05), but this was not
the case when comparing the CHR versus the PLC-C trial.
Furthermore, responders had significantly higher post-trial
blood lactate concentrations than non-responders in
both the ACU (P < 0.05) and the CHR trials (P < 0.05)
(Figure 2).
The analysis of the time effects for BE and bicarbon-
ate showed similar results (Figures 3 and 4). The post-
ingestion values were significantly higher than the basal= 5) and non-responders (n = 5) comparing acute (ACU) versus
antly different in the ACU versus PLC-A (P < 0.05). Each line represents
Table 1 Physical characteristics (mean ± SEM) of both the









All 14.9 ± 0.4 63.5 ± 4.0 168.6 ± 8.3 21.0 ± 0.6
Responders (n = 5) 15.4 ± 0.5 67.4 ± 4.1 172.2 ± 4.7 22.1 ± 1.1
Non-Responders (n = 5) 14.4 ± 0.4 59.3 ± 3.8 163.7 ± 2.2 19.8 ± 0.6
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analysis, the post-ingestion values in the ACU and the
CHR trials were found to be significantly higher than
the basal (P < 0.05) and post-trial values (P < 0.05). As ex-
pected, pH significantly decreased from post-ingestion to
post trial (P < 0.05); however, pH only slightly increased
(P = 0.07) from basal to post-ingestion in the ACU trial
(Figure 5). Furthermore, PCO2 significantly decreased
from post-ingestion to post-trial (P < 0.05).
The between group comparisons indicated that basal
BE (Figure 3) was significantly higher in the CHR trial
versus the ACU trial (P < 0.05). Post-ingestion BE was
significantly higher in the ACU versus the PLC-A trial
(P < 0.05), and in the CHR versus the PLC-C trial (P <
0.05), suggesting a significant pre-exercise alkalosis in both
ACU and CHR trials. However, there were no post-trial
differences in BE between the Na-CIT supplementation
trials and their corresponding placebo (Figure 3). As ex-
pected, post-ingestion bicarbonate concentrations were
significantly different in both the ACU (P < 0.05) and CHR
(P < 0.05) treatment conditions compared to their corre-
sponding placebo (Figure 4). There was also a small, non-
significant difference in the post-ingestion pH (P = 0.06)
between the ACU and the PLC-A trial (Figure 5). How-
ever, there were no post-trial differences in bicarbonate
concentration between the Na-CIT supplementation trialsFigure 2 Post-trial lactate concentrations (mmol/L) of responders and
trial (PLC-A). bSignificantly different (P < 0.05) from non-responders in the a
in the chronic (CHR) trial. Values are Mean ± SEM.and their corresponding placebo. Similarly, PCO2 values
were not significantly different between conditions.
Discussion
This is the first study to investigate the potential ergogenic
effects of Na-CIT in adolescent athletes. Ten, well-trained,
adolescent swimmers performed four 200 m time trials at
maximal effort, using two different Na-CIT supplementa-
tion protocols: ACU and CHR each with a corresponding
placebo (PLC-A and PLC-C). The main finding was that
acute supplementation of Na-CIT provided adequate pre-
exercise alkalosis but did not result in an improved 200 m
swimming performance or higher post-trial blood lactate
concentrations in all young swimmers. This is also the first
study to apply a chronic Na-CIT supplementation regimen
in an effort to improve performance while minimizing GI
discomfort. Indeed, the swimmers were regularly asked
throughout the study if any GI discomfort occurred and
none was reported. However, in our sample of adolescent
swimmers, the chronic supplementation of Na-CIT did
not have an effect on performance despite its significant
pre-exercise alkalosis effect.
With all 10 swimmers included in the analysis, the
200 m performance times did not appear to improve
with either the ACU or the CHR supplementation. Na-
CIT is postulated to work predominantly as an alkalizing
agent; however, more study is needed on its intracellular
effects. Lactate facilitation out of working muscle is in-
creased under alkalotic conditions compared to placebo
[5]. However, post-trial lactate concentrations were also
not statistically different between trials. The literature is
predominantly in agreement; lactate concentrations are
significantly higher post-trial with Na-CIT ingestion com-
pared to control or placebo [4,11-14], even when perform-
ance outcomes were not improved with supplementationnon-responders. aSignificantly different (P < 0.05) from acute placebo
cute (ACU) trial. cSignificantly different (P < 0.05) from non-responders
Figure 3 Base excess (BE) (mmol/L) at basal, post-ingestion, and post-trial time points for the acute placebo (PLC-A), acute (ACU),
chronic (CHR) and chronic placebo (PLC-C) trials. aSignificant difference during post-ingestion (P < 0.05) between ACU and PLC-A. bSignificant
difference during post-ingestion (P < 0.05) between CHR and PLC-C. cSignificant difference during basal (P < 0.05) between CHR and ACU. Significant
time effects (P < 0.05) basal to post-ingestion in ACU and PLC-C. Significant time effects (P < 0.05) post-ingestion to post-trial in ACU, CHR, and PLC-C.
Values are Mean ± SEM.
Russell et al. Journal of the International Society of Sports Nutrition 2014, 11:26 Page 6 of 9
http://www.jissn.com/content/11/1/26[2,3,29]. Therefore, a higher lactate concentration post-
trial, with Na-CIT ingestion, was expected.
It is well established that energy production through
anaerobic glycolysis during high-intensity exercise is
lower in children than adults [30,31]. This difference
has been explained by several mechanisms including re-
duced activity of PFK [32-35], lower activity of lactate
dehydrogenase [32-35], limited ability to recruit and use
type IIb motor units [34,36], and a greater reliance on
aerobic oxidative enzymes [30,32,34]. Furthermore, this
difference may be the reason for the smaller intramus-
cular pH change and lower lactate concentration found
in children and adolescents after maximal exercise com-
pared to adults [31-34,37].
Given these age related metabolic differences we fur-
ther investigated the potential to find participants thatFigure 4 Bicarbonate concentration (mmol/L) at basal, post-ingestion
(ACU), chronic (CHR) and chronic placebo (PLC-C) trials. aSignificant dif
bSignificant difference during post-ingestion (P < 0.05) between CHR and P
and PLC-C. Significant time effects (P < 0.05) post-ingestion to post-trial in Aresponded to Na-CIT at a greater magnitude than others.
Therefore, the data were analyzed for responders and
non-responders. Responders were chosen if they had
greater than 0.4% improvement, which corresponds to a
significant competitive improvement [27,28], in the
ACU versus PLC-A trials. Interestingly, the responders
(n = 5) were characterized with a higher mean age and
body size compared to non-responders, and had a 1.03%
mean performance improvement, which was greater than
expected and statistically significant, in the ACU but not
in the CHR trial. The acid–base response was favorable
post-ingestion amongst the responders. Similarly, post-
trial lactate concentrations were significantly higher in the
ACU trial as compared to its placebo, but not in the CHR
trial. When compared to non-responders, responders
had higher post-trial lactate concentrations in both the, and post-trial time points for the acute placebo (PLC-A), acute
ference during post-ingestion (P < 0.05) between ACU and PLC-A.
LC-C. Significant time effects (P < 0.05) basal to post-ingestion in ACU
CU, CHR, and PLC-C. Values are Mean ± SEM.
Figure 5 Blood pH at basal, post-ingestion, and post-trial time points for the acute placebo (PLC-A), acute (ACU), chronic (CHR) and
chronic placebo (PLC-C) trials. Significant time effects (P < 0.05) from basal to post-ingestion. Trend to significance (P = 0.06) during post-ingestion
between ACU and PLC-A. Values are Mean ± SEM.
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any ergogenic or ergolytic effect in non-responders, and
they did not attain typical blood lactate concentrations
after the 200 m time trials, as was observed for the re-
sponders. Therefore, those who developed higher post-
trial lactate levels benefited from the acute supplemen-
tation. These findings show a more active anaerobic me-
tabolism amongst the group of responders, which is
supported by the pre-mentioned age related differences.
Indeed the responders were older as a group. Further-
more, responders had greater BMI indicating a differ-
ence in body composition. It is, therefore, possible that
the responders had more muscle mass potentially enhan-
cing their use of Na-CIT, and subsequently their anaerobic
metabolism.
The effect on both swimming performance and plasma
alkalization was dependent on the supplementation proto-
col. The acute supplementation benefited the performance
of the responders; however, the chronic supplementation
did not lead to significant improvement or increase lactate
concentration. The CHR protocol was enacted to incre-
mentally increase plasma BE over a longer time period to
allow similar blood alkalization with a smaller dose at the
basal time point. The rationale behind the chronic dosing
supplementation was to minimize the potential for per-
formance inhibiting GI upset. Perhaps the CHR pre-trial
dose was insufficient to elicit performance enhancement,
even with the chronic dosing protocol over the previous
three days. Another factor could be the time between the
last chronic dose and the pre-trial dose of Na-CIT. Opti-
mally, the pre-trial dose would have been the morning
after the last chronic dose; however, the swims were per-
formed after school, in the late afternoon. Further experi-
mentation with the timing of the last chronic dose and the
pre-trial dose may be necessary to find an optimal proto-
col, should one existSample size was a limitation of this study as is for most
studies focused on athletic enhancement of specific age
groups. Considering the post-study analysis of responders
and non-responders, the absence of maturation data of
the participants was a limitation based on the conclusions
of this study. Differences in training volume may also be a
limitation to studies attempting multi-day trials over a
period of time. In addition, although allowing swimmers
to warm-up and race using their preferred routine and
stroke was chosen to improve motivation and real-life ap-
plication it is possible that the discrepancies in the warm-
up routines between swimmers and the different strokes
swam could have added some noise into the data that can-
not be controlled. Therefore, the study cannot answer
whether the degree of the observed effect (or lack thereof)
was mediated, at least in part, due to the different swim-
ming strokes and warm-up routines.Conclusions
This double-blinded, placebo controlled, cross-over trial
of Na-CIT supplementation did not show a significant
ergogenic effect in all adolescent swimmers. Specifically,
acute supplementation of Na-CIT provided sufficient
pre-exercise alkalosis (as shown by the higher BE and
bicarbonate) for performance improvement in 200 m
time trials in only half of the young swimmers, who
were older and had higher body mass. Post-trial blood
lactate concentrations were also higher for this group.
However, the chronic supplementation protocol was
not significantly advantageous for either responders or
non-responders though it did provide a significantly in-
creased BE and bicarbonate concentration post-ingestion.
Adequate timing of the CHR dosing before the trial day
may have been a factor in the lead up to the basal time
measurement.
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